Compare CGO & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CGO | MRCC |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Investment Managers |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 112.3M | 100.1M |
| IPO Year | N/A | 2011 |
| Metric | CGO | MRCC |
|---|---|---|
| Price | $10.74 | $4.46 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 30.0K | ★ 154.1K |
| Earning Date | 01-01-0001 | 03-05-2026 |
| Dividend Yield | ★ 9.25% | 8.00% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.71 | $4.11 |
| 52 Week High | $12.79 | $7.85 |
| Indicator | CGO | MRCC |
|---|---|---|
| Relative Strength Index (RSI) | 26.70 | 34.18 |
| Support Level | N/A | $4.11 |
| Resistance Level | $11.52 | $4.97 |
| Average True Range (ATR) | 0.21 | 0.21 |
| MACD | -0.06 | 0.03 |
| Stochastic Oscillator | 1.58 | 0.00 |
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the United States and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants. Its investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through investment in senior secured, unitranche secured and junior secured debt and, to a lesser extent, unsecured subordinated debt and equity investments.